Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) Liabilities-to-Assets Explanation
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
Orzaks Ilac Ve Kimyanayi Ticaret AS Liabilities-to-Assets Related Terms
Orzaks Ilac Ve Kimyanayi Ticaret AS Liabilities-to-Assets Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orzaks Ilac Ve Kimyanayi Ticaret AS Liabilities-to-Assets Chart
Orzaks Ilac Ve Kimyanayi Ticaret AS Annual Data
Trend
Dec23
Dec24
Dec25
Liabilities-to-Assets
0.60
0.49
0.56
Orzaks Ilac Ve Kimyanayi Ticaret AS Semi-Annual Data
Dec23
Dec24
Dec25
Liabilities-to-Assets
0.60
0.49
0.56
IST:ORZAX vs KHC, GIS: Liabilities-to-Assets Comparison
For the Packaged Foods subindustry, Orzaks Ilac Ve Kimyanayi Ticaret AS's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orzaks Ilac Ve Kimyanayi Ticaret AS Liabilities-to-Assets vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Orzaks Ilac Ve Kimyanayi Ticaret AS's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where Orzaks Ilac Ve Kimyanayi Ticaret AS's Liabilities-to-Assets falls into.
Orzaks Ilac Ve Kimyanayi Ticaret AS Liabilities-to-Assets Calculation
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a Liabilities-to-Assets of 0.56 as of Dec. 2025. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS's Liabilities-to-Assets too high?
Orzaks Ilac Ve Kimyanayi Ticaret AS's current Liabilities-to-Assets is 0.56. Overall, Orzaks Ilac Ve Kimyanayi Ticaret AS has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Orzaks Ilac Ve Kimyanayi Ticaret AS's Liabilities-to-Assets compare to KHC and GIS?
Orzaks Ilac Ve Kimyanayi Ticaret AS's Liabilities-to-Assets of 0.56 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Consumer Packaged Goods company?
A good Liabilities-to-Assets depends on the Consumer Packaged Goods industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors. Orzaks Ilac Ve Kimyanayi Ticaret AS's current Liabilities-to-Assets is 0.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS stock overvalued right now?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a current Liabilities-to-Assets of 0.56. The current Liabilities-to-Assets is 0.56. Orzaks Ilac Ve Kimyanayi Ticaret AS's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX), the current Liabilities-to-Assets is 0.56 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Orzaks Ilac Ve Kimya Sanayi Ticaret AS operates as a sports nutrition brand. Its products are Vitamin Series, Vitamin D Series, Mineral Series, Magnesium Series, Omega 3 Series, Plant Extracts, Immune Series, Probiotic Series, Bone And Joint Series, and Others. The group offers its products under various brands such as Ocean, Day2Day, Imunol, Cosakondrin, Efervit, Bigflor, and Strains.
18GF Score
Get the complete analysis for IST:ORZAX
Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:ORZAX has been successfully added to your 
